Media Centre

Featured Media Release
 

06 Mar 2013 - Fluarix® Product Notification

GlaxoSmithKline Australia (GSK) in consultation with the Therapeutic Goods Administration (TGA) has issued a product notification to healthcare professionals for its influenza vaccine Fluarix (Inactivated Split Influenza Vaccine).

 
 

Media Releases


GSK leads Access to Medicines Index 2014

The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.

17/11/2014

 

GSK announces multi-million dollar investment in next generation manufacturing

GSK Australia has announced today it will be investing AUD$31 million in next generation manufacturing technology to expand its Boronia site in the outer eastern suburbs of Melbourne.

14/11/2014

 

GSK transitions to online versions of Consumer Medicine Information (CMI) leaflets for prescription only medicines

To ensure we provide the most up-to-date consumer medicine information (CMI) to patients, GSK will no longer be providing CMI leaflets in medicine packs, including sample packs.

10/11/2014

 

Plant drugs and snail venom: Revolutionary drug research wins GSK award

20-year research program acknowledged with prestigious $80,000 GSK Award for Research Excellence

06/11/2014

 

Pharmacy/Wholesaler level recall of two batches of Zovirax® Ophthalmic Ointment (aciclovir 3%)

GSK Australia, in consultation with the Therapeutic Goods Administration (TGA), is initiating a voluntary pharmacy/wholesaler level recall of two batches of Zovirax® Ophthalmic Ointment (aciclovir 3%).

27/10/2014

 

Indigenous and refugee programs win immunisation boost

GSK’s 2014 Immunisation Grants have been awarded to programs that are helping improve access and awareness of vaccination services for Indigenous and refugee communities.

14/10/2014

 

Arzerra® (ofatumumab) registered in Australia for first-line use in chronic lymphocytic leukaemia (CLL)...

GlaxoSmithKline announced today that the Therapeutic Goods Administration (TGA) has registered Arzerra® (ofatumumab), a human monoclonal antibody, in combination with chlorambucil or bendamustine for the treatment of patients in Australia with...

03/10/2014

 

International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth

GSK, Monash University, McCall MacBain Foundation, Grand Challenges Canada and Planet Wheeler Foundation join forces to develop oxytocin dry powder inhaler

26/09/2014

 

Night time bathroom visits - a trigger for men to visit the doctor

New Australian campaign launched that focusses on enlarged prostates

11/09/2014

 

Kimbra launches campaign to urge effective asthma management

Asthma Awareness Week – Popular recording artist and asthma sufferer Kimbra is joining forces with asthma experts and peak respiratory health groups today to launch the Asthma: Take Control campaign. The national campaign is urging people affected...

02/09/2014

1 2 3 4 5 6 7 8 9 10 11 >